CXCR7 antagonist-1 (hydrochloride)
CAT:
804-HY-139643A-02
Size:
10 mM / 1 mL
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
CXCR7 antagonist-1 (hydrochloride)
- CAS Number: 2990472-61-0
- UNSPSC Description: CXCR7 antagonist-1 hydrochloride is a CXCR7 antagonist that inhibits the binding of the SDF-1 chemokine (also known as the CXCL12 chemokine) or I-TAC (also known as CXCL11) to the chemokine receptor CXCR7. CXCR7 antagonist-1 hydrochloride is useful in preventing tumor cell proliferation, tumor formation, inflammatory diseases, and many other diseases (extracted from patent WO2014085490A1, compound 1.128)[1].
- Target Antigen: CXCR
- Type: Reference compound
- Related Pathways: GPCR/G Protein;Immunology/Inflammation
- Applications: COVID-19-immunoregulation
- Field of Research: Cancer; Inflammation/Immunology
- Assay Protocol: https://www.medchemexpress.com/cxcr7-antagonist-1-hydrochloride.html
- Solubility: DMSO : 350 mg/mL (ultrasonic)
- Smiles: O=C(C1=NN(C2=CC=C(C=C2)F)C=C1)N[C@@H]3CN(CC3)C4=NC=CN5C4=CC=C5.[H]Cl
- Molecular Weight: 426.87
- References & Citations: [1]Junfa Fan, et al. Cxcr7 antagonists. Patent WO2014085490A1.
- Shipping Conditions: Room Temperature
- Clinical Information: No Development Reported